Passaggio dalla formula MDRD alla CKD-EPI: impatto sulla riclassificazione in stadi della malattia renale cronica

Adriano Anesi,Marco Casati,Marco Farina,Anna Lisa Tornesello,Dominga Baroni,Salvatore Pittalis
DOI: https://doi.org/10.1007/s13631-011-0040-5
2012-03-01
Abstract:BackgroundThe Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation has been proposed as a replacement for the Modification of Diet in Renal Disease (MDRD) equation as a method of estimating the glomerular filtration rate (eGFR) in routine clinical use. The aim of our study was to evaluate the correlation between these two equations, as well as the effect of introducing the CKD-EPI equation on the stratification of subjects into chronic kidney disease (CKD) stages, in two wide cohorts. The cohorts contained 186,575 and 28,349 outpatients aged 20–70 years, who had serum creatinine measurements performed with two different IDMS traceable methods at the reference laboratories for the areas of Monza and Lodi.MethodsSerum creatinine results, obtained between August 1, 2009 and August 1, 2010 using an enzymatic assay in the Monza laboratory and a kinetic alkaline picrate assay (Jaffe’s method) in the Lodi laboratory, were extracted from each laboratory database. The agreement between eGFRs calculated from the two formulas was evaluated by Bland and Altman plots. We also compared the prevalence of CKD stages for both equations and considered whether the difference between the equations might be related to variables such as age, sex or eGFR levels.ResultsThere was no difference between eGFR estimated by CKD-EPI and MDRD at values <60 mL/min/1.73 m2, whereas at higher values MDRD consistently underestimated eGFR with both analytical methods. The prevalence of CKD stage 2 was markedly lower with CKD-EPI (22.1% vs 43.2% with MDRD using an enzymatic assay, and 33.7% vs 52% with MDRD using Jaffe’s method) as was the prevalence of CKD stage 3 (4.2% vs 5.2% with MDRD using an enzymatic assay and 3.2% vs 4.6% with MDRD using Jaffe’s method).ConclusionsCompared with MDRD, the CKD-EPI equation produces higher levels of eGFR and lower estimated prevalence in early stages of CKD independent of the analytical method used for creatinine. These differences seem mostly relevant in women and among the 20–39 year age group with MDRD estimated GFRs of 30–59 mL/min/1.73 m2.
What problem does this paper attempt to address?